Literature DB >> 17900655

Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis.

Rosalyn Díaz1, Ji Won Kim, Jia-Ji Hui, Zhaodong Li, Gary P Swain, Keith S K Fong, Katalin Csiszar, Pierre A Russo, Elizabeth B Rand, Emma E Furth, Rebecca G Wells.   

Abstract

The epithelial to mesenchymal transition has recently been implicated as a source of fibrogenic myofibroblasts in organ fibrosis, particularly in the kidney. There is as yet minimal evidence for the epithelial to mesenchymal transition in the liver. We hypothesized that this process in biliary epithelial cells plays an important role in biliary fibrosis and might be found in patients with especially rapid forms, such as is seen in biliary atresia. We therefore obtained liver tissue from patients with biliary atresia as well as a variety of other pediatric and adult liver diseases. Tissues were immunostained with antibodies against the biliary epithelial cell marker CK19 as well as with antibodies against proteins characteristically expressed by cells undergoing the epithelial to mesenchymal transition, including fibroblast-specific protein 1, the collagen chaperone heat shock protein 47, the intermediate filament protein vimentin, and the transcription factor Snail. The degree of colocalization was quantified using a multispectral imaging system. We observed significant colocalization between CK19 and other markers of the epithelial to mesenchymal transition in biliary atresia as well as other liver diseases associated with significant bile ductular proliferation, including primary biliary cirrhosis. There was minimal colocalization seen in healthy adult and pediatric livers, or in livers not also demonstrating bile ductular proliferation. Multispectral imaging confirmed significant colocalization of the different markers in biliary atresia. In conclusion, we present significant histologic evidence suggesting that the epithelial to mesenchymal transition occurs in human liver fibrosis, particularly in diseases such as biliary atresia and primary biliary cirrhosis with prominent bile ductular proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900655     DOI: 10.1016/j.humpath.2007.05.021

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  53 in total

1.  Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia.

Authors:  Yu-Hua Deng; Cong-Lun Pu; Ying-Cun Li; Jin Zhu; Chunping Xiang; Ming-Man Zhang; Chun-Bao Guo
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.

Authors:  Michel Fausther; Elise G Lavoie; Jonathan A Dranoff
Journal:  Curr Pathobiol Rep       Date:  2013-09

3.  Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.

Authors:  Axel-M Gressner; Chun-Fang Gao; Olav-A Gressner
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

4.  Foxa1 and Foxa2 regulate bile duct development in mice.

Authors:  Zhaoyu Li; Peter White; Geetu Tuteja; Nir Rubins; Sara Sackett; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

5.  Hedgehog signaling in biliary fibrosis.

Authors:  Linda E Greenbaum
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.

Authors:  Alessia Omenetti; Alessandro Porrello; Youngmi Jung; Liu Yang; Yury Popov; Steve S Choi; Rafal P Witek; Gianfranco Alpini; Juliet Venter; Hendrika M Vandongen; Wing-Kin Syn; Gianluca Svegliati Baroni; Antonio Benedetti; Detlef Schuppan; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 7.  Emerging concepts in biliary repair and fibrosis.

Authors:  Luca Fabris; Carlo Spirli; Massimiliano Cadamuro; Romina Fiorotto; Mario Strazzabosco
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

Review 8.  Cholangiocyte proliferation and liver fibrosis.

Authors:  Shannon S Glaser; Eugenio Gaudio; Tim Miller; Domenico Alvaro; Gianfranco Alpini
Journal:  Expert Rev Mol Med       Date:  2009-02-25       Impact factor: 5.600

Review 9.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

Review 10.  Cellular sources of extracellular matrix in hepatic fibrosis.

Authors:  Rebecca G Wells
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.